Swiss photonic solutions involving thin-film lithium niobate (TFLN). Versics AG offers electro-optic modulators, transmitters and lightwave component analyzers based on TFLN that operate up to 110 GHz efficiently. The products are assembled with standard optical and electrical connectors, and the compact form factor guarantees excellent integration in your testbeds.
Venture Valuation AG/Biotechgate
Venture Valuation specializes in independent asset and company valuation of biotechnology, biopharma, life sciences and medical technology. Valuations are provided for fundraising, investment decision, portfolio valuations, in- and out-licensing, arbitration/fairness opinions and M&A. The company has developed “Biotechgate”, which is business development and licensing database for the life sciences industry. Company Valuation: The Company Valuation Reports include a thorough assessment of the company by experienced professionals with expertise in the relevant fields as well as the following elements: • summary of key risk parameters and strengths of the company • outline of the crucial factors and value drivers for growth and further strategic development • assessment of the management, market, science, technology and products • analysis of the company’s business model and the company’s competitive environment • detailed calculation of the company’s financial value, using appropriate valuation methods Product Valuation: Venture Valuation offers detailed Product Valuation Reports of pre-clinical and clinical products in development that can serve as a basis for negotiations or to structure different deal scenarios. The Product Valuation includes: • detailed analysis of development costs, time lines, patient population, competing products, pricing and product life cycle • industry gold standard rNPV valuation methodology based on indication-specific attrition rates and the development stage • scenario and sensitivity analyses • analysis of the current value, and forecasts of the future value following the successful completion of key development milestones As an “add on” module and based on Venture Valuation’s deal database within Biotechgate, benchmarking deals can also be included to provide the client with a differentiated negotiation basis and comparable information.
Switzerland Global Enterprise
Switzerland Global Enterprise (S-GE) is the official Swiss organization for export and investment promotion. S-GE supports Swiss SMEs in their international business and helps innovative foreign companies on their way to settling in Switzerland. As a private organization, S-GE has acted on behalf of the Swiss Confederation and cantons since 1927 to ensure strength in the country’s foreign trade and prosperity in Switzerland. | Are you thinking about taking your business to the next level and contributing to innovative, sustainable solutions for the future? Think Switzerland! Consider Switzerland Global Enterprise (S-GE) and our Swiss Business Hubs around the world your partner, with the network, tools and resources needed to make informed location and investment decisions. A leading position in relevant innovation ecosystems, access to talents, partners and markets, a liberal economic system, political stability, an excellent education system and a high standard of living are among the factors that make Switzerland the most competitive business center in the world. Our country adds value to businesses that want to increase scale and impact. Switzerland Global Enterprise is here to help you navigate Switzerland’s business and innovation environment. Our service is free of charge. INFORM We help with your location analysis. We provide you with data and information to get a clear picture of how Switzerland can add value as leading innovation ecosystem, specifically to your needs. This includes information on legal, tax and administrative conditions, the regulatory environment, salary costs and talent. We help you benchmark Switzerland with other countries and regions on your shortlist. VISIT To really experience what working and living in Switzerland feels like, we facilitate managed site visits – in person or virtual – tailored to your interests and industry-specific ecosystem. This gives you the opportunity to engage with local peers and hear how they successfully use Switzerland as base for their business. CONNECT Meet our regional and cantonal partner organizations, talk to industry experts, consult with recruiters and connect with universities and research centers – we happily provide you with contacts and introductions that kick-off and accelerate your growth in Switzerland. YOUR INVESTMENT TEAM ACROSS THE GLOBE In addition to our offices in Switzerland, we have a network of 22 Swiss Business Hubs integrated into the Swiss diplomatic missions abroad. Would you like to know more about what Switzerland has to offer as a business location? Select your regional office and get in touch. | Switzerland Global Enterprise (S-GE) is the official Swiss organization dedicated to export and investment promotion. With a presence in over 130 markets worldwide, S-GE supports Swiss companies in expanding their international footprint and assists innovative foreign companies in establishing operations in Switzerland. At S-GE, we understand the power of connections. Our services are designed to foster meaningful relationships between Swiss companies and international partners, creating a robust network that drives success abroad. One platform to create visibility for the Swiss Biotech Industry is the SWISS Pavilion at the most relevant biotech shows worldwide. It offers a great platform for Swiss companies and organizations to be present in the markets and to connect to the international biotech community. | Grüezi and welcome to Switzerland! Switzerland Global Enterprise (S-GE) is the organizer of the SWISS Pavilion, the official Swiss participation at MD&M West 2026. We offer support and consulting services for export from Switzerland abroad and investing in Switzerland. We proudly state that our stand covers 18 Swiss companies showcasing just the perfect blend of services. Visit us at the booth no 2861 – 3066. The SWISS Pavilion – a meeting place full of opportunities!
SWISS Pavilion
Switzerland at BIO 2025: Innovation, Collaboration, and Global Impact Welcome to the SWISS Pavilion at BIO International Convention 2025 – your gateway to one of the world’s most dynamic and resilient biotech ecosystems. Switzerland stands at the forefront of global biotechnology, driven by a unique blend of scientific excellence, international collaboration, and a deep commitment to innovation that benefits patients and partners worldwide. Switzerland’s biotech industry continues to demonstrate remarkable strength and adaptability. According to the Swiss Biotech Report 2025, the sector attracted CHF 2.5 billion in capital investment in 2024 – a 22% increase over the previous year – despite global economic headwinds. This growth reflects the confidence of international investors in Swiss innovation and the country’s ability to deliver breakthrough solutions in healthcare, diagnostics, and life sciences. With over 1,000 biotech companies and a dense network of academic institutions, research centers, and global pharma leaders, Switzerland offers a fertile environment for biotech innovation. The industry contributes significantly to the national economy, with life sciences accounting for over 50% of Swiss exports. This year’s Swiss Biotech Report emphasizes the importance of international collaboration. Four out of five biotech patents filed in Switzerland are the result of cross-border partnerships. Swiss companies are not only developing therapies for the local market – they are building global business cases, forming strategic alliances, and co-developing solutions that address some of the world’s most pressing health challenges. At the SWISS Pavilion, you’ll find a curated selection of Switzerland’s most promising biotech innovators – from agile startups and academic spin-offs to established scale-ups and research-driven SMEs. While each exhibitor brings a unique value proposition, together they represent the full spectrum of Swiss biotech excellence: – Next-generation therapeutics: From immuno-oncology to gene and cell therapies, Swiss companies are advancing novel treatment modalities with global potential. – Cutting-edge diagnostics: Precision medicine is a key focus, with technologies that enable earlier, more accurate, and personalized diagnosis. – Digital health and AI: Swiss innovators are integrating data science and machine learning into biotech workflows, accelerating discovery and improving patient outcomes. – Sustainable biomanufacturing: Several exhibitors are pioneering green biotech solutions and scalable production platforms. – Academic and regional clusters: The Pavilion also features representatives from Switzerland’s leading biotech hubs, including the Basel Area, the Greater Zurich Area, and Greater Geneva Bern area, showcasing the country’s decentralized yet interconnected innovation landscape. Why visit the SWISS Pavilion? – Meet high-potential partners: Engage with companies actively seeking international collaborations, licensing opportunities, and investment. – Explore innovation across the value chain: From early-stage research to clinical development and commercialization. – Experience Swiss quality and reliability: A hallmark of Swiss biotech is its commitment to scientific rigor, regulatory excellence, and long-term partnerships. Whether you’re looking for your next strategic partner, investment opportunity, or simply want to explore the future of biotech, the SWISS Pavilion is your destination at BIO 2025. Join us in shaping the future of global health – the Swiss way. | Switzerland at BIO 2026: Innovation, Collaboration, and Global Impact Welcome to the SWISS Pavilion at BIO International Convention 2026 – your gateway to one of the world’s most dynamic and resilient biotech ecosystems. Switzerland stands at the forefront of global biotechnology, driven by a unique blend of scientific excellence, international collaboration, and a deep commitment to innovation that benefits patients and partners worldwide. Switzerland’s biotech industry continues to demonstrate remarkable strength and adaptability. According to the Swiss Biotech Report 2025, the sector attracted CHF 2.5 billion in capital investment in 2024 – a 22% increase over the previous year – despite global economic headwinds. This growth reflects the confidence of international investors in Swiss innovation and the country’s ability to deliver breakthrough solutions in healthcare, diagnostics, and life sciences. With over 1,000 biotech companies and a dense network of academic institutions, research centers, and global pharma leaders, Switzerland offers a fertile environment for biotech innovation. The industry contributes significantly to the national economy, with life sciences accounting for over 50% of Swiss exports. This year’s Swiss Biotech Report emphasizes the importance of international collaboration. Four out of five biotech patents filed in Switzerland are the result of cross-border partnerships. Swiss companies are not only developing therapies for the local market – they are building global business cases, forming strategic alliances, and co-developing solutions that address some of the world’s most pressing health challenges. At the SWISS Pavilion, you’ll find a curated selection of Switzerland’s most promising biotech innovators – from agile startups and academic spin-offs to established scale-ups and research-driven SMEs. While each exhibitor brings a unique value proposition, together they represent the full spectrum of Swiss biotech excellence: – Next-generation therapeutics: From immuno-oncology to gene and cell therapies, Swiss companies are advancing novel treatment modalities with global potential. – Cutting-edge diagnostics: Precision medicine is a key focus, with technologies that enable earlier, more accurate, and personalized diagnosis. – Digital health and AI: Swiss innovators are integrating data science and machine learning into biotech workflows, accelerating discovery and improving patient outcomes. – Sustainable biomanufacturing: Several exhibitors are pioneering green biotech solutions and scalable production platforms. – Academic and regional clusters: The Pavilion also features representatives from Switzerland’s leading biotech hubs, including the Basel Area, the Greater Zurich Area, and Greater Geneva Bern area, showcasing the country’s decentralized yet interconnected innovation landscape. Why visit the SWISS Pavilion? – Meet high-potential partners: Engage with companies actively seeking international collaborations, licensing opportunities, and investment. – Explore innovation across the value chain: From early-stage research to clinical development and commercialization. – Experience Swiss quality and reliability: A hallmark of Swiss biotech is its commitment to scientific rigor, regulatory excellence, and long-term partnerships. Whether you’re looking for your next strategic partner, investment opportunity, or simply want to explore the future of biotech, the SWISS Pavilion is your destination at BIO 2026. Join us in shaping the future of global health – the Swiss way. | Swissenviro was founded in 2015 by Urs Heutschi. It is a small, privately-owned company and the organizer of the SWISS Pavilion at international trade fairs for environmental technologies. With more than 20 years of experience, the international fair work is our area of expertise and forms the core of our work. The aim is to support export-orientated Swiss Cleantech SME to find buyers and business partners in international markets by encouraging international networking and direct B2B contacts on trade fairs and other events. By participation in a Joint Swiss Booth, the “SWISS Pavillon”, we are bringing together Swiss SMEs with professional trade visitors – potential future buyers, partners or suppliers. If desired, we gladly accompany and support the SME further on its business project resulting from this first customer contact. We closely work together with relevant Swiss environmental associations such as Cleantech Alps, VSA and Energie-Cluster. For our SWISS Pavilions we are supported by the MPK from “Switzerland Global Enterprise” (S-GE) and the “Swiss Federal Office for the Environment” (FOEN).
Swiss Business Hub USA
The Swiss Business Hub USA is the New York-based representative of the official international trade and investment promotion agency Switzerland Global Enterprise (S-GE). Part of the Consulate General of Switzerland in New York and with offices in San Francisco, Atlanta and Boston (Cambridge), it is responsible for implementing Swiss export strategies in the US and for promoting Switzerland as a business location. The Swiss Business Hub USA provides localized support, market information, consulting and networking services to Swiss companies venturing into the US market. In addition, the Swiss Business Hub actively promotes Switzerland as a highly attractive business and investment location for US companies looking for growth in Switzerland and in Europe. The Swiss Business Hub proactively contacts and informs US-based companies about the key advantages of Switzerland as a business and investment location. The Swiss Business Hub USA has a first-rate network of contacts both in the US and in Switzerland. | The Swiss Business Hub USA is the New York-based representative of the official international trade and investment promotion agency Switzerland Global Enterprise (S-GE). Part of the Consulate General of Switzerland in New York and with offices in San Francisco, Atlanta and Boston (Cambridge), it is responsible for implementing Swiss export strategies in the US and for promoting Switzerland as a business location.
Swiss Biotech Association
Founded in 1998, the Swiss Biotech Association represents the interests of the Swiss biotech industry. To support its members in a competitive market, the Swiss Biotech Association works to secure favorable framework conditions and facilitate access to talents, novel technologies and financial resources. To strengthen and promote the Swiss biotech industry, the Swiss Biotech Association collaborates with numerous partners and life science clusters globally under the brand Swiss Biotech™.
Superlab Suisse AG
Superlab Suisse is a lab provider aiming to create a global platform for life science companies. Our ready-to-move-in lab space with a Lab-as-a-Service offering includes BSL1/2 laboratory facilities, state-of-the-art equipment, and professional concierge services for startups, scaleups and established companies in the biopharma arena. The concept was born out of a deep admiration for scientific researchers and their work – we reinvented and modernized the components that make up a laboratory with the aim of bolstering efficiency and radically improving the workplace experience. At Superlab, you get a first taste of the labs of the future. | X
Rivia AG
x | RIVIA is the first Trial Intelligence platform with Agentic AI tools for modern sponsors. It brings all clinical and operational data into one single view, giving sponsors real-time control of the clinical development and saving up to 30% of the monitoring costs. All-in-one. All in real time. No more waiting on the CROs.
PULSE
EPIC Suisse purchases and develops attractive real estate, invests in their optimisation, and retains the properties in its portfolio over a long term. PULSE is the newest development of EPIC Suisse and a cutting-edge multimodal innovation center. On a total space of circa 43,000 m2 PULSE is located in Cheseaux-sur-Lausanne, Switzerland in the heart of the health valley, 45 minutes from Geneva by car. PULSE is ready to be rented out – tenant fit out starts summer 2024! | PULSE (www.pulse.swiss) is a modern and forward-looking innovation center for new generation companies within the life science and innovation sector. Located in Cheseaux sur Lausanne in the heart of the health valley and part of the Greater Geneva Bern Area (GGBA). Key facts: 43’000m² of fully modular floor space above ground / 2 Buildings / 450 parking lots / 27’000m² of parking / storage / technical process areas in basement / 8 Independent entrances / 12 Unloading bays. BioTech, life science, and other high-tech companies have high demands when it comes to workspace that can make it difficult to find a good fit. PULSE is a new cutting-edge multi modular innovation center created with your needs in mind. We offer: Super flexible floor plans and floor heights with high-capacity goods lifts. You can customize your space to your company’s exact specifications. Technical capacities corresponding to the most stringent requirements, with air flows adapted and sized specifically for laboratories/white rooms and adjustable high-voltage electrical power. Possibility of creative synergies within an ecosystem of different innovative companies as well as an array of features that appeal to employees such as childcare, fitness center, and dining opportunities. 8 separate entrances on the ground floor allowing for you to have a clear identity, a unique address, and an easy orientation for employees and clients. A premium architecture and settings within the popular Greater Geneva Bern Area (GGBA) that is sure to impress visitors and customers.
Polaroid Therapeutics
Polaroid Therapeutics, founded in 2022, is a healthcare company focused on developing innovative antimicrobial solutions for wound healing and additional indications with unmet medical needs. As a spinoff of Polaroid Sciences, our mission is to bring to life the best of Polaroid’s vision of creating a more human and meaningful world through cutting-edge technology and research. Our proprietary technology is designed to address major challenges in antimicrobial therapies and improve patient outcomes. We are committed to positively impacting the lives of patients and their families by delivering superior treatments that prevent, heal, and improve the quality of life. We aspire to reach and help all humankind around the globe.